GRI Bio
1 hedge funds and large institutions have $5.09M invested in GRI Bio in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
13,496% more capital invested
Capital invested by funds: $37.4K → $5.09M (+$5.05M)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$8.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$8.21K |
| 2 |
State Street
Boston,
Massachusetts
|
-$6.84K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.46K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.01K |
| 5 |
AIC
Archer Investment Corporation
Carmel,
Indiana
|
-$36 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
Altium Capital Management
New York
| $5.01M | +$8.89M | +27 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $63.8K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $11K | – | – | – |
|
4
UBS Group
Zurich,
Switzerland
| $3.82K | – | – | – |
|
5
Wells Fargo
San Francisco,
California
| $85 | – | – | – |
|
|
AIC
6
Archer Investment Corporation
Carmel,
Indiana
| – | -$36 | – | – |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$4.01K | – | – |
|
|
8
State Street
Boston,
Massachusetts
| – | -$6.84K | – | – |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$5.46K | – | – |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$8.21K | – | – |
|
GRI Hedge Fund Activity: Q2 2023 in Review
1 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in GRI Bio (GRI) for Q2 2023, worth a combined $5.09M — up 13,496% from $37.4K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GRI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $8.89M. The largest seller was Two Sigma Securities, cutting an estimated $8.21K.
- 1 institutional investor held GRI Bio (GRI) as of Q2 2023, up from 0 in Q1 2023.
- Funds reported $5.09M of GRI Bio stock for Q2 2023, up 13,496% quarter-over-quarter.
- 1 fund opened new GRI Bio positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest GRI Bio buyer in Q2 2023 was Altium Capital Management, an estimated $8.89M added.
- The largest GRI Bio seller in Q2 2023 was Two Sigma Securities, an estimated $8.21K sold.
Based on aggregated 13F filings for Q2 2023.